Ganirelix Acetate
Back to searchMolecule Structure
Scientific Name
Ganirelix Acetate
Description of the Drug
Ganirelix is a GnRH antagonist used in assisted reproduction in women undergoing controlled ovarian hyperstimulation to control ovulation by inhibiting the premature LH surges.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06785
http://www.drugbank.ca/drugs/DB06785
Brand Name(s)
Ganirelix acetate, Ganirelix Acetate Injection, Orgalutran
Company Owner(s)
Hong Kong King Friend Industrial Co Ltd, Sun Pharmaceutical Industries Ltd, Amphastar Pharmaceuticals Inc, Organon Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL19712192 | ||
| DrugBank | DB06785 | ||
| PubChem: Thomson Pharma | 14793014 | ||
| PubChem | 16130957 | ||
| Nikkaji | J419.572H | ||
| BindingDB | 50102454 | ||
| DrugCentral | 1279 | ||
| ChemicalBook | CB61370494 | CB62130570 | CB9775895 |
| rxnorm | GANIRELIX | GANIRELIX ACETATE | |
| ChEBI | 135910 |
